ORIC Pharmaceuticals Inc. · 2 days ago
Senior Vice President/Vice President, Regulatory Affairs
ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by overcoming resistance in cancer. The Senior Vice President/Vice President, Regulatory Affairs, is responsible for developing and executing global regulatory strategies and overseeing the company's development pipeline from preclinical through commercialization.
BiopharmaBiotechnologyHealth CarePharmaceuticalTherapeutics
Responsibilities
Provide oversight for global regulatory affairs in all major regions (North America, Europe, Asia Pacific, Latin America) for all regulatory functions, including Clinical, Non-clinical, Regulatory Operations, and broad oversight for Regulatory CMC and Regulatory Diagnostics
Represent ORIC and act as a company spokesperson (or delegate with oversight) in communications with regulatory authorities
Ensure high-quality and timely regulatory submissions (IND/CTA/NDA/MAA/PMA) in compliance with all applicable regulatory requirements, and in alignment with corporate goals
Provide strategic input on all regulatory activities in support of product development plan, lifecycle management, and post-approval planning
Supervise and develop regulatory direct reports
Provide management with regulatory due diligence advice for potential new product opportunities
Grow corporate, project and industry knowledge
Analyze and communicate current Regulatory issues and information to senior management and other departmental personnel
Qualification
Required
Advanced degree (PhD, PharmD, MD, or MS) in a life sciences or health-related discipline desired
At least 15 years of biopharma regulatory and quality experience, with 10+ years focused on oncology and late-stage development, including post-regulatory approval product launch experience
Previous experience directing and coordinating FDA and other Health Authority interactions
Demonstrated success leading major regulatory submissions (NDA/BLA/MAA) through approval
Experience with electronic filings (e.g., eCTD)
Company
ORIC Pharmaceuticals Inc.
ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer.
Funding
Current Stage
Public CompanyTotal Funding
$533MKey Investors
SR OneNextech InvestPfizer
2025-05-28Post Ipo Equity· $125M
2024-01-30Post Ipo Equity· $125M
2023-06-26Post Ipo Equity· $85M
Recent News
2025-12-24
2025-12-18
2025-12-18
Company data provided by crunchbase